Sage Therapeutic Stock Price on October 7, 2024

SAGE Stock  USD 5.47  0.08  1.44%   
Below is the normalized historical share price chart for Sage Therapeutic extending back to July 18, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sage Therapeutic stands at 5.47, as last reported on the 2nd of December, with the highest price reaching 5.59 and the lowest price hitting 5.42 during the day.
IPO Date
18th of July 2014
200 Day MA
11.4974
50 Day MA
6.5282
Beta
0.924
 
Yuan Drop
 
Covid
If you're considering investing in Sage Stock, it is important to understand the factors that can impact its price. Sage Therapeutic owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.098, which indicates the firm had a -0.098% return per unit of risk over the last 3 months. Sage Therapeutic exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sage Therapeutic's Coefficient Of Variation of (1,075), variance of 22.17, and Risk Adjusted Performance of (0.06) to confirm the risk estimate we provide.
  
The current year's Total Stockholder Equity is expected to grow to about 802.6 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 45.7 M. . At present, Sage Therapeutic's Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1.70, whereas Price Earnings Ratio is forecasted to decline to (2.51). Sage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.098

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSAGE

Estimated Market Risk

 4.68
  actual daily
41
59% of assets are more volatile

Expected Return

 -0.46
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average Sage Therapeutic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sage Therapeutic by adding Sage Therapeutic to a well-diversified portfolio.
Price Book
0.6064
Enterprise Value Ebitda
(0.33)
Price Sales
3.1909
Shares Float
48.5 M
Wall Street Target Price
9.4706

Related Headline

Terns Pharmaceuticals Headline on 7th of October 2024

FOSTER CITY, Calif., Oct. 07, 2024 -- Terns Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that it has granted as of October 1, 2024 an equity inducement award to a new employee under the terms of the 2022 Employment Inducement Award Plan, as amended . The equit

Sage Therapeutic Valuation on October 7, 2024

It is possible to determine the worth of Sage Therapeutic on a given historical date. On October 7, 2024 Sage was worth 6.58 at the beginning of the trading date compared to the closed value of 6.72. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sage Therapeutic stock. Still, in general, we apply an absolute valuation method to find Sage Therapeutic's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sage Therapeutic where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sage Therapeutic's related companies.
 Open High Low Close Volume
  6.63    7.04    6.47    6.64    867,457  
10/07/2024
  6.58    6.74    6.45    6.72    462,327  
  6.00    6.90    5.84    6.43    751,232  
Backtest Sage Therapeutic  |  Sage Therapeutic History  |  Sage Therapeutic Valuation   PreviousNext  
Open Value
6.58
6.72
Closing Value
20.61
Upside

Sage Therapeutic Trading Date Momentum on October 7, 2024

On October 08 2024 Sage Therapeutic was traded for  6.43  at the closing time. The top price for the day was 6.90  and the lowest listed price was  5.84 . The trading volume for the day was 751.2 K. The trading history from October 8, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 4.32% . The trading price change against the current closing price is 7.89% .

Sage Therapeutic Fundamentals Correlations and Trends

By evaluating Sage Therapeutic's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sage Therapeutic's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sage financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Sage Therapeutic Stock history

Sage Therapeutic investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sage Therapeutic will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sage Therapeutic stock prices may prove useful in developing a viable investing in Sage Therapeutic
Last ReportedProjected for Next Year
Common Stock Shares Outstanding59.8 M45.7 M
Net Loss-479.5 M-455.5 M

Sage Therapeutic Quarterly Net Working Capital

544.58 Million

Sage Therapeutic Stock Technical Analysis

Sage Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Sage Therapeutic technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sage Therapeutic trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Sage Therapeutic Period Price Range

Low
December 2, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Sage Therapeutic cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Sage Therapeutic December 2, 2024 Market Strength

Market strength indicators help investors to evaluate how Sage Therapeutic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sage Therapeutic shares will generate the highest return on investment. By undertsting and applying Sage Therapeutic stock market strength indicators, traders can identify Sage Therapeutic entry and exit signals to maximize returns

Sage Therapeutic Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Sage Therapeutic's price direction in advance. Along with the technical and fundamental analysis of Sage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Sage Stock analysis

When running Sage Therapeutic's price analysis, check to measure Sage Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sage Therapeutic is operating at the current time. Most of Sage Therapeutic's value examination focuses on studying past and present price action to predict the probability of Sage Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sage Therapeutic's price. Additionally, you may evaluate how the addition of Sage Therapeutic to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume